Trial intelligence / Profile preview

Efficacy of artemether + lumefantrine and dihydroartemisinin + piperaquine for pediatric malaria in Burkina Faso

PACTR201708002499311Not yet recruiting

Sponsor
Improving Malaria Care
Start
Sep 2017
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of artemether, lumefantrine, dihydroartemisinin and piperaquine in malaria and Malaria (2 arms), sponsored by Improving Malaria Care. Planned start Sep 2017; status: not yet recruiting.

02

Drugs

artemetherlumefantrinedihydroartemisininpiperaquine
03

Conditions

malariaMalaria

Beyond the preview

Go deeper on PACTR201708002499311.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201708002499311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call